Literature DB >> 19079755

Chemical engineering of nanogel drug carriers: increased bioavailability and decreased cytotoxicity.

Serguei V Vinogradov1, Ekta Kohli, Arin Zeman, Alexander V Kabanov.   

Abstract

Entities:  

Year:  2006        PMID： 19079755      PMCID： PMC2601575     

Source DB:  PubMed          Journal:  Polymer Prepr        ISSN： 0032-3934


× No keyword cloud information.
  7 in total

1.  Cross-linked polymeric nanogel formulations of 5'-triphosphates of nucleoside analogues: role of the cellular membrane in drug release.

Authors:  Serguei V Vinogradov; Ekta Kohli; Arin D Zeman
Journal:  Mol Pharm       Date:  2005 Nov-Dec       Impact factor: 4.939

Review 2.  Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells.

Authors:  Serguei V Vinogradov; Tatiana K Bronich; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2002-01-17       Impact factor: 15.470

3.  Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine.

Authors:  M A Gosselin; W Guo; R J Lee
Journal:  Bioconjug Chem       Date:  2001 Nov-Dec       Impact factor: 4.774

4.  Cytotoxic and antitumor activities of doxorubicin conjugates with the epidermal growth factor and its receptor-binding fragment.

Authors:  S V Lutsenko; N B Feldman; S E Severin
Journal:  J Drug Target       Date:  2002-11       Impact factor: 5.121

5.  Comparison of nanogel drug carriers and their formulations with nucleoside 5'-triphosphates.

Authors:  Serguei V Vinogradov; Ekta Kohli; Arin D Zeman
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.200

6.  Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.

Authors:  Serguei V Vinogradov; Arin D Zeman; Elena V Batrakova; Alexander V Kabanov
Journal:  J Control Release       Date:  2005-09-20       Impact factor: 9.776

7.  Nanogels for oligonucleotide delivery to the brain.

Authors:  Serguei V Vinogradov; Elena V Batrakova; Alexander V Kabanov
Journal:  Bioconjug Chem       Date:  2004 Jan-Feb       Impact factor: 4.774
  7 in total
  5 in total

1.  Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.

Authors:  Carlos M Galmarini; Galya Warren; Madapathage T Senanayake; Serguei V Vinogradov
Journal:  Int J Pharm       Date:  2010-05-24       Impact factor: 5.875

Review 2.  Polymeric nanogel formulations of nucleoside analogs.

Authors:  Serguei V Vinogradov
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

Review 3.  Nanogels as pharmaceutical carriers: finite networks of infinite capabilities.

Authors:  Alexander V Kabanov; Serguei V Vinogradov
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

4.  Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.

Authors:  Xin Wei; Thulani H Senanayake; Galya Warren; Serguei V Vinogradov
Journal:  Bioconjug Chem       Date:  2013-04-02       Impact factor: 4.774

5.  Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition.

Authors:  Xin Wei; Thulani H Senanayake; Anna Bohling; Serguei V Vinogradov
Journal:  Mol Pharm       Date:  2014-08-05       Impact factor: 4.939
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.